Cardiovascular diseases
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients who have been treated with PCPS during the period from April 1, 2012 to March 31, 2020
Exclusion criteria
Exclusion criteria: (1) Patients who have difficulties to discontinue PCPS after on-pompcardiovascular surgery (2) In a case when the patients or patients' guardian (parental authority) provid disagreement for participating this study (3) Patients whose principal investigators or sub-investigators consider unsuitable to participate in this study (4) Patients under 2-year-old at the time of PCPS induction (5) Patient using VV-ECMO (6) The patient who was scheduled PCPS for coronary intervention or catheter ablation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Factors affecting successful weaning from PCPS: Background factors; 1) age, 2) time to induction (within 30 minutes), 3) underlying heart diseases (ischemic heart disease with successful revascularization, acute myocarditis, pulmonary embolism), 4) creatinine value at PCPS induction, Daily factors; 5) PCPS flow rate/rotation speed, 6) use of IABP, 7) use of hemodialysis, 8) blood pressure, 9) lactate level, 10) total bilirubin value,11) hemorrhagic complications. Regression coefficient in the prediction model for PCPS discontinuation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Predicted value and measured value by the prediction model for PCPS successful weaning. Proportion of in-hospital death and survival discharge after PCPS successful weaning. Neurological prognosis. Number of days before PCPS discontinuation, survival discharge, and in-hospital death. | — |
Countries
Japan
Contacts
National Hospital Organization Yokohama Medical Center Cardiology